National
Lonza to acquire five US manufacturing sites from Merck in expansion drive
Source: Healthcaremea|
1 min read
The expanded network will strengthen Lonza’s capacity across bioconjugates, high-potency compounds, viral vectors and lipid-based delivery technologies.